A Karasik
Overview
Explore the profile of A Karasik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ilany J, Michael L, Cohen O, Matetzky S, Gorfine M, Hod H, et al.
Exp Clin Endocrinol Diabetes
. 2011 Mar;
119(8):463-6.
PMID: 21374547
Background: Most non diabetic patients admitted with acute coronary syndrome (ACS) demonstrate an abnormality in glucose homeostasis. It was claimed that an oral glucose tolerance test (OGTT) undertaken during the...
2.
Chiasson J, Josse R, Gomis R, Hanefeld M, Karasik A, Laakso M
Diabetologia
. 2004 May;
47(6):969-75.
PMID: 15164169
The STOP-NIDDM Trial has shown that acarbose treatment in subjects with impaired glucose tolerance is associated with a significant risk reduction in the development of diabetes, hypertension and cardiovascular complications....
3.
Goshen E, Cohen O, Rotenberg G, Oksman Y, Karasik A, Zwas S
Nucl Med Commun
. 2003 Sep;
24(9):959-61.
PMID: 12960594
The therapeutic approach to recurrent well-differentiated thyroid cancer is based on the detection of active disease. While a measured increase of thyroglobulin level in an ablated patient is highly suggestive...
4.
Beery R, Haimsohn M, WERTHEIM N, Hemi R, Nir U, Karasik A, et al.
Endocrinology
. 2001 Jun;
142(7):3098-107.
PMID: 11416032
Aurintricarboxylic acid (ATA), an endonuclease inhibitor, prevents the death of a variety of cell types in culture. Previously we have shown that ATA, similar to insulin-like growth factor I (IGF-I),...
5.
Karasik A, Shimon I
Pituitary
. 2001 Jun;
3(3):181-4.
PMID: 11383483
We describe four young patients (age 19-34 years) with hypopituitarism following closed head injury. The diagnosis was made by demonstration of low basal pituitary hormone levels and dynamic tests showing...
6.
Cauley J, Norton L, Lippman M, Eckert S, Krueger K, Purdie D, et al.
Breast Cancer Res Treat
. 2001 Mar;
65(2):125-34.
PMID: 11261828
Raloxifene, a selective estrogen receptor modulator approved for the prevention and treatment of postmenopausal osteoporosis, has shown a significant reduction in breast cancer incidence after 3 years in this placebo-controlled,...
7.
Olchovsky D, Berezin M, Ghodsizade A, Zahavi Z, Karasik A, Rechavi G, et al.
Hum Mutat
. 2000 Sep;
16(3):269.
PMID: 10980535
Multiple endocrine neoplasia type 1 (MEN-1) is characterized by hyperfunction and tumor formation of the parathyroids, anterior pituitary and endocrine pancreas. We carried out exon-specific, PCR-based DNA sequencing of the...
8.
Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, et al.
Nat Med
. 2000 May;
6(5):568-72.
PMID: 10802714
Insulin gene expression is restricted to islet beta cells of the mammalian pancreas through specific control mechanisms mediated in part by specific transcription factors. The protein encoded by the pancreatic...
9.
Cohen O, Einav Y, Cohen Y, Karasik A, Ferber S
Transplantation
. 2000 May;
69(7):1464-70.
PMID: 10798772
Background: Transplantation of engineered beta cell-derived lines is a promising modality for cell-based therapy of diabetes mellitus. The in vivo environment and antirejection and other medications may have significant effects...
10.
Olchovsky D, Nativ O, Resnick M, Rechavi G, Karasik A, Friedman E
Hum Mutat
. 1999 Oct;
14(5):448.
PMID: 10533077
No abstract available.